I would the numbers are good enough to apply for the BTD.
Advaxis licensed their canine vaccine to Anatera. The Anatera presentation clearly shows the median survival for the treatment group as triple the control group. I'm thinking the darn thing works. Would this be considered a "material" event! Since the canine osteosarcoma clearly mimics the same condition in humans and Advaxis wants to start a pediatric trial, I cannot understand why they haven't mentioned it yet. I've sent emails and called but nothing yet. Thought?
I hope they PR the canine data. Three times better than the control group, They should be shouting this off rooftops, "IT WORKS!!!!"
I believe Mikey has genital herpes. He has a strange fascination with warts. Always talks about them. I think there's something not quite right with him.